Cargando…
Evidence on neuroprotective properties of coenzyme Q10 in the treatment of glaucoma
Glaucoma, the leading cause of visual impairment and irreversible blindness worldwide, is a multifactorial, progressive optic neuropathy characterized by loss of retinal ganglion cells, alterations of the optic nerve head, and specific visual field defects. Clinical evidence shows that intraocular p...
Autores principales: | Martucci, Alessio, Nucci, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301180/ https://www.ncbi.nlm.nih.gov/pubmed/30530997 http://dx.doi.org/10.4103/1673-5374.244781 |
Ejemplares similares
-
Combined use of coenzyme Q10 and citicoline: A new possibility for patients with glaucoma
por: Martucci, Alessio, et al.
Publicado: (2022) -
Neuroprotective agents in the management of glaucoma
por: Nucci, C., et al.
Publicado: (2018) -
Natural Products: Evidence for Neuroprotection to Be Exploited in Glaucoma
por: Adornetto, Annagrazia, et al.
Publicado: (2020) -
Coenzyme Q and its role in glaucoma
por: Ahmad, Syed S.
Publicado: (2020) -
The promise of neuroprotection by dietary restriction in glaucoma
por: Russo, Rossella, et al.
Publicado: (2021)